Stem Cell Diagnosis and Evaluation

Explore evaluation processes used to determine suitability for stem cell treatments.

Learn the steps for Stem Cell Diagnosis and Evaluation, including specialized blood tests, bone marrow biopsy, and genetic testing for stem cell disorders.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

The Diagnostic Trajectory

The Diagnostic Trajectory

The diagnosis of Thalassemia is a precise exercise in hematological investigation. Unlike some conditions, which rely on subjective symptoms for diagnosis, Thalassemia is diagnosed through objective quantitative analysis of blood. In many countries with high prevalence, such as Turkey, universal screening programs—including premarital and newborn screening—have revolutionized the landscape, enabling the identification of carriers and affected infants before clinical symptoms appear.

Icon LIV Hospital

Hematological Analysis

Hematological Analysis

The initial suspicion of Thalassemia typically arises from a Complete Blood Count (CBC).

  • Microcytic Hypochromic Anemia: The hallmark finding is red blood cells that are unusually small (low Mean Corpuscular Volume, or MCV) and pale (low Mean Corpuscular Hemoglobin, or MCH).
  • Erythrocytosis: Paradoxically, carriers (Thalassemia Minor) often have a higher-than-normal number of red blood cells, even though they are anemic. This distinguishes them from patients with iron-deficiency anemia, who typically have a low red cell count.
  • Peripheral Smear: A microscopic examination reveals “target cells” (cells that look like a bullseye), teardrop cells, and varying sizes and shapes of red cells (anisopoikilocytosis). In untreated Major cases, nucleated red blood cells (immature cells commonly found only in marrow) appear in the circulation.
Icon 1 LIV Hospital

Hemoglobin Electrophoresis and HPLC

Hemoglobin Electrophoresis and HPLC

Confirmatory diagnosis relies on analyzing the specific types of hemoglobin present.

  • High-Performance Liquid Chromatography (HPLC): the gold standard. It separates and quantifies the different hemoglobin fractions.
  • Beta-Thalassemia Findings: In Beta-Thalassemia Major, there is a near-total absence of Hemoglobin A (adult hemoglobin). Instead, the blood contains mainly Hemoglobin F (fetal hemoglobin) and Hemoglobin A2. In Beta-Thalassemia Trait, Hemoglobin A2 is essentially elevated (>3.5%).
  • Alpha-Thalassemia Findings: This is harder to diagnose by electrophoresis in adults. In newborns, the presence of Hemoglobin Bart’s indicates Alpha-Thalassemia.
Icon LIV Hospital

Molecular Genetic Testing

Molecular Genetic Testing

DNA analysis is the ultimate arbiter of diagnosis, especially for determining prognosis and eligibility for regenerative therapies.

  • Mutation Analysis: PCR (Polymerase Chain Reaction) and gene sequencing identify the specific mutation in the globin genes. There are hundreds of known mutations. Knowing the particular genotype (e.g., Beta-Zero vs. Beta-Plus) helps predict whether a patient will be transfusion-dependent (Major) or may have a milder course (Intermediate).
  • Family Studies: Genetic testing of parents and siblings is mandatory to identify carriers and, crucially, to find a potential stem cell donor.
Icon 1 LIV Hospital

Evaluation for Regenerative Therapy (HSCT)

Evaluation for Regenerative Therapy (HSCT)

Once a diagnosis of Thalassemia Major is confirmed, the focus shifts to evaluating the patient for a curative stem cell transplant. This is a comprehensive physiological audit.

HLA Typing (Human Leukocyte Antigen)

This is the most critical step. HLA markers are cell-surface proteins that regulate the immune system.

  • Sibling Matching: Full siblings are tested first, as they have a 25% chance of being a perfect match.
  • High-Resolution Typing: Advanced DNA-based typing is used to ensure the donor and recipient are matched at the allele level, minimizing the risk of rejection or Graft-Versus-Host Disease.

Assessment of Iron Burden

Before transplant, the extent of iron overload must be quantified, as excess iron increases the toxicity of the transplant conditioning.

  • Serum Ferritin: A blood protein that correlates with total body iron stores.
  • Liver Iron Concentration (LIC): The most accurate measure. It can be measured via biopsy (invasive) or, more commonly now, via MRI (Ferriscan or T2*).
  • Cardiac MRI (T2*): This measures iron deposition in the heart muscle. Severe cardiac iron overload is a significant risk factor and may require aggressive chelation treatment before transplant.

Organ Function Testing

  • Hepatic Evaluation: Liver function tests and ultrasound to check for fibrosis or cirrhosis caused by iron or hepatitis.
  • Endocrine Evaluation: Tests for thyroid function, glucose tolerance (diabetes), and hormone levels.
  • Infectious Screening: Screening for transfusion-transmitted infections like Hepatitis B, C, and HIV.

Prenatal Diagnosis

Prenatal Diagnosis

For couples who are both carriers, prenatal diagnosis is available.

  • Chorionic Villus Sampling (CVS): Performed at 11 weeks of gestation to test fetal DNA.
  • Preimplantation Genetic Diagnosis (PGD): Used in conjunction with IVF. Embryos are tested for Thalassemia before implantation. Crucially, PGD can also be used to select an embryo that is an HLA match for an older sick sibling, creating a “savior sibling” who can serve as a cord blood donor.

30
Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical expertise and hospitality to every individual who walks through our doors.  

Book a Free Certified Online Doctor Consultation

Doctors

Table of Contents

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is the difference between iron deficiency anemia and Thalassemia trait?

Both conditions cause small, pale red blood cells (microcytosis). However, iron deficiency is caused by a lack of iron and is characterized by low ferritin levels. Thalassemia trait is genetic; iron levels are typically normal or high. Mistaking Thalassemia trait for iron deficiency is dangerous because giving iron supplements to a Thalassemia carrier can cause iron overload.

Yes. Hemoglobin F (fetal hemoglobin) is a healthy type of hemoglobin. Patients with Thalassemia who naturally continue to produce high levels of Hemoglobin F often have milder symptoms because the F-hemoglobin compensates for the lack of A-hemoglobin and protects the red cells from damage.

A savior sibling is a child conceived through IVF with Preimplantation Genetic Diagnosis (PGD). The embryo is selected to be free of Thalassemia and a perfect HLA match for an older sibling with Thalassemia Major. Stem cells from the newborn’s umbilical cord are used to transplant and cure the older child.

While electrophoresis confirms the type of Thalassemia, genetic testing identifies the exact mutation. This helps predict the severity of the disease (genotype-phenotype correlation) and is essential for prenatal testing for future pregnancies and for checking family members.

Liver biopsy was historically the gold standard for measuring iron load, but it is invasive. Today, specialized MRI scans (called T2* or R2 MRI) can accurately measure iron levels in the liver and heart without needles, so biopsies are rarely needed for this purpose anymore.

Spine Hospital of Louisiana